Keywords: herceptin, heads, cancer, drugs, backed, usa, genentech

Herceptin Heads Cancer Drugs Backed In USA

Article | 10 September 1998

Genentech's humanized monoclonal antibody Herceptin (trastuzumab) hasbeen unanimously recommended for approval by the US Food and Drug Administration's Oncologic Drugs ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Genentech

Go to company listing

Related Drugs

Herceptin

trastuzumab

Valstar

Valrubicin

Porfimer Sodium

Go to drug listing